We are pleased to announce an MoU with JSS Medical College and Academy of Higher Education and Research, Mysuru to work together in the areas of hemoglobinopathies and rare diseases. The aim is to work on collaborative projects to develop affordable and efficient diagnostics, therapeutics, and treatment options.
Related Posts
Antimicrobial Resistance has become a ‘silent pandemic’
Speaking to The Hindu, Dr. Rakesh Mishra, Director, TIGS highlights the threat... read more
OneHealth national agenda meeting
A meeting at Indian Institute for Science (IISc), involving various academic, research... read more
An Uphill Battle
Dr. Vasanth Thamodaran, Senior Scientist at TIGS was featured in an article... read more
On rising COVID-19 cases in several countries
There is need to exercise caution and follow COVID19 appropriate norms &... read more
Quick sequencing offers a better chance at COVID control
The SARS-CoV-2 virus has an opportunity to change every time it replicates... read more
Agricultural biotechnology: Gene editing versus gene modification, The Indian Express, 30 Jan 2020
Delegate visit from University of Manchester
We were pleased to host a delegation from University of Manchester led... read more
Why environmental surveillance for avian influenza is vital
Wastewater-based epidemiology or pathogen surveillance has become an integral component of environmental surveillance... read more
PhD Admissions 2023
TIGS is proud to host a PhD program in collaboration with the... read more
Hybrid immunity will end pandemic
Are vaccines safe? Is booster dose required? Does COVID19 vaccine affect children? In... read more